Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Sheba Medical Center.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Sheba Medical Center Identifier:
First received: February 2, 2006
Last updated: March 28, 2012
Last verified: March 2012